NASDAQ: VTVT
Vtv Therapeutics Inc Stock Ownership - Who owns Vtv Therapeutics?

Insider buying vs selling

Have Vtv Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul J. SekhriPres CEO and Exec Chairperson2024-11-181,844$16.96
$31.27kBuy
Paul J. SekhriPres CEO and Exec Chairperson2024-11-151,778$16.88
$30.01kBuy
Paul J. SekhriPres CEO and Exec Chairperson2024-11-151,378$16.35
$22.53kBuy

1 of 1

VTVT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTVT insiders and whales buy or sell their stock.

VTVT Shareholders

What type of owners hold Vtv Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ronald O. Perelman1,218.32%38,919,878$769.06MInsider
G42 Investments Ai Holdings Rsc Ltd325.12%10,386,274$205.23MInsider
Tahnoon Bin Zayed S. Alnahyan325.12%10,386,274$205.23MInsider
Samsara Biocapital GP LLC6.47%206,784$4.09MInsider
Srinivas Akkaraju6.47%206,784$4.09MInsider
Samsara Biocapital LLC6.47%206,784$4.09MInstitution
Fmr LLC5.58%178,200$3.52MInstitution
Baker Bros Advisors LP4.26%135,946$2.69MInsider
Baker Bros Advisors LP3.05%97,314$1.92MInstitution
Paul G. Savas2.87%91,781$1.81MInsider

1 of 3

VTVT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTVT0.96%99.04%Net Buying
ADVM30.21%69.79%Net Buying
ALGS6.61%93.39%
COEP0.33%99.67%
PMVP56.07%43.93%Net SellingNet Selling

Vtv Therapeutics Stock Ownership FAQ

Who owns Vtv Therapeutics?

Vtv Therapeutics (NASDAQ: VTVT) is owned by 18.38% institutional shareholders, 1,895.00% Vtv Therapeutics insiders, and 0.00% retail investors. Ronald O. Perelman is the largest individual Vtv Therapeutics shareholder, owning 38.92M shares representing 1,218.32% of the company. Ronald O. Perelman's Vtv Therapeutics shares are currently valued at $769.06M.

If you're new to stock investing, here's how to buy Vtv Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.